Open Label Pilot Trial of Rituximab in Lupus Membranous Nephritis

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2008

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Lupus Nephritis
Interventions
DRUG

Rituximab

375mg/m2 q week x 4; repeated in 6 months

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Northwell Health

OTHER

NCT00908986 - Open Label Pilot Trial of Rituximab in Lupus Membranous Nephritis | Biotech Hunter | Biotech Hunter